Pay in 4 interest-free payments of $7.08 Learn more
Ships within 48 hours · Estimated delivery Aug 13 - Aug 18
Efficacy of liraglutide for weight loss among patients with type 2 diabetes: The SCALE Diabetes Randomized Clinical Trial
A March 2021 study posted in the New England Journal of Medicine reported on the speed and amount of weight loss for participants using Semaglutide versus a placebo
Advanced technology like SculpSure highlights their commitment to non-invasive treatments
Only Wegovy and Saxenda have been approved for use as weight-loss medications by Health Canada
Pricing note: All pricing information was based on publicly available information at the time of publication (January 2026) and is subject to change
Given its extended systemic half-life (approximately 5 days) and potent dual-receptor agonism, weekly intervals provide a stable pharmacokinetic profile without causing overlapping receptor saturation or acute hypoglycemic events. Route of Administration The standard and thoroughly documented route in clinical literature is Subcutaneous (SubQ) injection, typically in the abodmen
